Developer docs
API playgroundTry for free, no card

Search company profiles

Belong.Life

Full company profile

uuid0004os1

Namestring
Belong.Life
Legal namestring
BelongLife Inc
Websiteurl
belong.life
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Belong.Life, founded in 2015 and headquartered in New York with parent Belongtail Ltd in Bnei Atarot, Israel, is a digital health company that builds AI-powered patient engagement platforms and large-scale patient communities for people with chronic diseases. Its product portfolio centers on the BelongAI Health Mentor platform, which includes proprietary conversational AI mentors: Dave (cancer), Sophie (multiple sclerosis), Tara (clinical trial matching), and Fred (weight management). These are layered on top of condition-specific communities, including Belong Cancer and BelongMS (each described as the world's largest social and professional patient community in their respective disease areas), BelongIBD, and BelongPSO. On the enterprise side, the company offers Smart Clinic AI, a browser-based clinical workflow automation tool for hospitals and clinics, and a white-label patient engagement platform that pharmaceutical companies, payers, and providers deploy under their own brands.

The underlying technology stack combines generative AI, NLP, recommendation engines, and process automation, wrapped with proprietary ARCH guardrails to support health-grade GenAI deployment. Smart Clinic AI is reported to save an average of 20 minutes per visit, reduce administrative workload by up to 60%, enable 40% more patients per day, and maintain over 90% accuracy, with HIPAA, GDPR, and ISO/IEC 27001:2022 compliance. Belong.Life's GTM combines product-led growth through freemium iOS/Android consumer apps with enterprise field sales to hospitals and pharma, plus an OEM/white-label channel through pharmaceutical partners.

Revenue is generated through a combination of in-app premium subscriptions for consumer features, white-label enterprise licensing to pharmaceutical companies and payers, and direct SaaS sales of Smart Clinic AI to hospital and clinic systems. Named enterprise customers include ten or more major pharmaceutical companies (Janssen, Roche, Novartis, Sanofi, AstraZeneca, Bayer, AbbVie, MSD, Takeda, Teva), leading hospital systems in Israel and Canada (Sheba, Tel Aviv Sourasky, Rambam, Assuta Ashdod, Jewish General Hospital), the Israel Ministry of Health, and research institutions including NCI and McGill University. The company has raised approximately $40 million across three funding rounds from 2017 through 2021, with IQVIA among the named investors.

Short descriptiontext

Belong.Life builds AI-powered patient engagement platforms and the world's largest social networks for cancer and multiple sclerosis patients, serving pharmaceutical companies, hospitals, payers, and chronic disease patients across Israel, the U.S., and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health platform, patient engagement software, AI health mentors, clinical workflow automation, chronic disease communities
Industry3 codes
1Patient Community, Peer Support & Social Engagement
CodeHLACAEAKPrimaryYes
2Adherence, Reminders & Engagement Automation (Medication/Follow-up)
CodeHLACAEAJPrimaryNo
3Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
CodeHLALABAJPrimaryNo
NAICS code2 codes
  • Other Individual and Family Services624190
  • Offices of Other Health Practitioners6213
SIC code2 codes
  • Services-Health Services8000
  • Services-Prepackaged Software7372
Product category
Digital Health Patient Engagement Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Freemium App Model
TypeFreemium
Description

Core apps (Belong Cancer, BelongMS, etc.) are free for patients; premium features offered via in-app subscriptions through iOS App Store and Google Play with monthly/annual billing.

belong.life
2Enterprise White-Label Licensing
TypeSubscription Recurring
Description

Private-label deployment of BelongAI technology to healthcare providers, pharmaceutical companies, and payers for branded patient engagement experiences. Delivered as a platform/subscription model to organizations.

belong.life
3Smart Clinic AI Enterprise Sales
TypeSubscription Recurring
Description

Browser-based clinical automation solution sold to hospitals and clinics in Israel, U.S., and Europe, streamlining intake and administrative workflows.

belong.life
4Premium Subscriptions (Paid Services)
TypeSubscription Recurring
Description

In-app subscription purchases for premium features and content, auto-renewing monthly or annually. Reasonable use policy with cap of up to 80 weekly posts & chats with AI mentor.

belong.life
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Free tier with basic community access and limited AI mentor interactions
ModelFreemiumBilling cadenceMonthly
Notes

Core community features and basic AI mentor access free. Premium subscriptions unlock additional features with up to 80 weekly posts & chats with AI mentor under reasonable use policy.

belong.life
2Premium subscription with enhanced AI mentor access and features
ModelSubscriptionBilling cadenceAnnual
Notes

Auto-renewing subscriptions through iOS App Store or Google Play. Annual subscriptions include 30-60 day advance renewal notices. Price changes communicated via app or account email.

belong.life
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 7 records shown
1BelongAI Cancer Mentor (Dave)
Description

World's first proactive conversational AI Cancer Mentor, medically validated by world-leading physicians, providing proactive support and guidance powered by a community of peers.

belong.life
+6 more records
Core offering1 text field

Belong.Life develops and operates AI-powered patient engagement platforms combining generative-AI health mentors and disease-specific social/professional patient communities. Consumer-facing mobile apps (BelongAI Cancer Mentor Dave, BelongMS, BelongIBD, BelongPSO, Weight Mate Fred, Belong Cancer) provide 24/7 AI-driven guidance and peer support to patients with chronic conditions. Enterprise offerings include Smart Clinic AI, which automates clinical intake and administrative workflows for hospitals and clinics, and a white-label BelongAI platform licensed to pharmaceutical companies, payers, and clinical trial organizations for branded patient engagement deployments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Saves an average of 20 minutes per visit for clinics using Smart Clinic AI
+3 more records
Product overview1 text field

Belong.Life is a global digital health company offering a multi-product platform combining AI-powered patient engagement tools with large-scale patient communities. The portfolio includes BelongAI Dave Cancer Mentor (a medically validated conversational AI companion), Smart Clinic AI (enterprise clinical workflow automation), Fred AI Weight Mate, consumer disease-specific communities (Belong Cancer, BelongMS, BelongIBD, BelongPSO), and enterprise solutions for Pharma, Payers, Hospitals/Clinics, Media Advertisers, and Clinical Trials. The company delivers these solutions on a private-label (white-label) basis. Products are available as mobile apps (iOS/Android) and web platforms, with all solutions sharing common AI infrastructure and compliance certifications (HIPAA, GDPR, ISO 27001).

Product and service8 records
1BelongAI Dave — Cancer Mentor
CategoryAI Health Mentor (consumer mobile app)
Description

A proactive conversational AI cancer mentor mobile app that delivers 24/7 personalized support, guidance, and clinical-trial matching to cancer patients; medically validated by physicians and powered by a community of peers; available on iOS and Android as a freemium app with optional premium subscription.

2Belong Cancer
CategoryPatient Community (consumer mobile app)
Description

The world's largest social and professional network for cancer patients, caregivers, and healthcare professionals, providing community engagement, peer support, wellness resources, and education via a free, anonymous mobile app.

3BelongMS
CategoryPatient Community (consumer mobile app)
Description

The world's largest social and professional network for multiple sclerosis patients and caregivers, offering free, anonymous community support, resources, and tools for living with MS via a mobile app.

4Smart Clinic AI
CategoryEnterprise clinical workflow automation (SaaS)
Description

Browser-based AI clinical workflow automation platform that automates patient intake, pre-visit interviews, document collection, and medical record summarization for hospitals and clinics; reduces administrative work by up to 60%, saves about 20 minutes per visit, and enables clinics to see up to 40% more patients per day at over 90% AI accuracy.

5Fred — AI Weight Mate
CategoryAI Health Mentor (consumer mobile app)
Description

AI-powered mobile weight and health mentor that proactively supports users throughout weight loss, weight maintenance, and balanced living with personalized guidance.

6BelongIBD
CategoryPatient Community (consumer mobile app)
Description

Mobile patient community app providing support, education, and peer connection for patients with inflammatory bowel disease, Crohn's disease, and colitis.

7BelongPSO
CategoryPatient Community (consumer mobile app)
Description

Mobile patient community app delivering support, education, and peer connection for patients living with psoriasis.

8iBelong
CategoryPatient Community (consumer mobile app)
Description

Additional branded patient engagement app within the Belong.Life ecosystem offering patient community and engagement services.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major Israeli hospital partnering with Belong.Life for patient engagement solutions and research collaborations

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading Israeli medical center using Belong.Life patient engagement platforms

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major Israeli hospital partnering with Belong.Life for patient engagement

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company using Belong.Life's white-label patient engagement platform

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company partnering with Belong.Life for patient engagement solutions

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company using Belong.Life's white-label patient engagement technology

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company partnering with Belong.Life for patient engagement

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company using Belong.Life patient engagement platforms

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company partnering with Belong.Life for patient engagement

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company using Belong.Life's white-label patient engagement platform

11MSD
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company partnering with Belong.Life for patient engagement solutions

belong.life
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Pharmaceutical company using Belong.Life patient engagement platforms

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Israeli pharmaceutical company partnering with Belong.Life for patient engagement

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical validation research published at ASCO congresses on BelongAI Dave Cancer Mentor accuracy and clinical utility

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical validation research published at ESMO congresses on BelongAI Cancer Mentor accuracy and recommendations

Strategic tierStrategicTypeTechnology or Integration
Description

Healthcare data and analytics company collaborating with Belong.Life for research and data capabilities

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic research partnership with Belong.Life for clinical research and validation studies

Strategic tierCoreTypeStrategic or Co-development Partner
Description

U.S. National Cancer Institute partnering with Belong.Life for cancer patient engagement research

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Nonprofit lung cancer organization partnering with Belong.Life for patient support and community engagement

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Breast health nonprofit partnering with Belong.Life for patient community and support programs

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GetWellNetwork provides patient engagement, education, and workflow automation to hospitals and health systems — directly comparable to Belong's Smart Clinic AI and enterprise hospital channel.

TypeEmerging player
Description

Ada Health builds AI-driven symptom assessment and health navigation tools — overlapping with BelongAI's conversational guidance and clinical-trials matching use cases, though focused on triage rather than chronic-disease mentorship.

TypeDirect peer
Description

PatientsLikeMe runs patient communities with structured health data and research partnerships, including pharma-sponsored modules — overlapping directly with Belong's community-plus-data monetization model.

TypeDirect peer
Description

CipherHealth offers patient engagement, outreach, and care-navigation platforms to hospitals and health systems — overlapping with Belong's Smart Clinic AI patient intake and follow-up workflow automation.

TypeDirect peer
Description

HealthUnlocked hosts condition-specific patient communities used by patient organizations and pharma — the closest pure community-platform analogue to Belong's flagship products.

TypeDirect peer
Description

MyHealthTeams operates social networks for people living with chronic conditions (MS, breast cancer, autism, etc.) — directly comparable to Belong Cancer and BelongMS as condition-specific patient communities with pharma-sponsored programming.

TypeDirect peer
Description

Omada Health delivers digital chronic-disease management (diabetes, hypertension, weight) with payer and employer channels — comparable in chronic-condition focus, payer distribution, and quantified outcomes to Belong's payer enterprise solutions.

TypeBroad incumbent
Description

Verily (Alphabet) operates large-scale patient engagement, real-world data, and care management platforms across multiple conditions — a well-capitalized incumbent that competes with Belong's pharma, payer, and clinical-trial offerings at greater scale.

TypeDirect peer
Description

Sidekick Health delivers digital therapeutics and engagement platforms for chronic conditions with pharma and payer partnerships — directly comparable to Belong's condition-specific apps and enterprise white-label model.

TypeEmerging player
Description

Massive Bio's Tara provides AI-powered oncology clinical-trial matching — directly comparable to BelongAI Tara (clinical trials matching) for pharma and CRO customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Belong.Life

Digital Health Patient Engagement Softwarebelong.life

Belong.Life builds AI-powered patient engagement platforms and the world's largest social networks for cancer and multiple sclerosis patients, serving pharmaceutical companies, hospitals, payers, and chronic disease patients across Israel, the U.S., and Europe.

What Belong.Life does

Belong.Life, founded in 2015 and headquartered in New York with parent Belongtail Ltd in Bnei Atarot, Israel, is a digital health company that builds AI-powered patient engagement platforms and large-scale patient communities for people with chronic diseases. Its product portfolio centers on the BelongAI Health Mentor platform, which includes proprietary conversational AI mentors: Dave (cancer), Sophie (multiple sclerosis), Tara (clinical trial matching), and Fred (weight management). These are layered on top of condition-specific communities, including Belong Cancer and BelongMS (each described as the world's largest social and professional patient community in their respective disease areas), BelongIBD, and BelongPSO. On the enterprise side, the company offers Smart Clinic AI, a browser-based clinical workflow automation tool for hospitals and clinics, and a white-label patient engagement platform that pharmaceutical companies, payers, and providers deploy under their own brands.

The underlying technology stack combines generative AI, NLP, recommendation engines, and process automation, wrapped with proprietary ARCH guardrails to support health-grade GenAI deployment. Smart Clinic AI is reported to save an average of 20 minutes per visit, reduce administrative workload by up to 60%, enable 40% more patients per day, and maintain over 90% accuracy, with HIPAA, GDPR, and ISO/IEC 27001:2022 compliance. Belong.Life's GTM combines product-led growth through freemium iOS/Android consumer apps with enterprise field sales to hospitals and pharma, plus an OEM/white-label channel through pharmaceutical partners.

Revenue is generated through a combination of in-app premium subscriptions for consumer features, white-label enterprise licensing to pharmaceutical companies and payers, and direct SaaS sales of Smart Clinic AI to hospital and clinic systems. Named enterprise customers include ten or more major pharmaceutical companies (Janssen, Roche, Novartis, Sanofi, AstraZeneca, Bayer, AbbVie, MSD, Takeda, Teva), leading hospital systems in Israel and Canada (Sheba, Tel Aviv Sourasky, Rambam, Assuta Ashdod, Jewish General Hospital), the Israel Ministry of Health, and research institutions including NCI and McGill University. The company has raised approximately $40 million across three funding rounds from 2017 through 2021, with IQVIA among the named investors.

Belong.Life firmographics

Firmographics
Name
Belong.Life
Legal name
BelongLife Inc
Website
https://belong.life
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Belong.Life builds AI-powered patient engagement platforms and the world's largest social networks for cancer and multiple sclerosis patients, serving pharmaceutical companies, hospitals, payers, and chronic disease patients across Israel, the U.S., and Europe.
Ownership category
akta.pro rank

Belong.Life industry classification

Industry
Product category
Digital Health Patient Engagement Software
NAICS
Other Individual and Family Services (624190), Offices of Other Health Practitioners (6213)
SIC
Services-Health Services (8000), Services-Prepackaged Software (7372)
akta.pro primary industry
Patient Community, Peer Support & Social Engagement (HLACAEAK)
akta.pro secondary industries
Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

  • Digital health platform
  • Patient engagement software
  • AI health mentors
  • Clinical workflow automation
  • Chronic disease communities

Where Belong.Life is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Belong.Life business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Freemium App Model: Core apps (Belong Cancer, BelongMS, etc.) are free for patients; premium features offered via in-app subscriptions through iOS App Store and Google Play with monthly/annual billing.
  2. Enterprise White-Label Licensing: Private-label deployment of BelongAI technology to healthcare providers, pharmaceutical companies, and payers for branded patient engagement experiences. Delivered as a platform/subscription model to organizations.
  3. Smart Clinic AI Enterprise Sales: Browser-based clinical automation solution sold to hospitals and clinics in Israel, U.S., and Europe, streamlining intake and administrative workflows.
  4. Premium Subscriptions (Paid Services): In-app subscription purchases for premium features and content, auto-renewing monthly or annually. Reasonable use policy with cap of up to 80 weekly posts & chats with AI mentor.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree tier with basic community access and limited AI mentor interactions
SubscriptionAnnualPremium subscription with enhanced AI mentor access and features

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Belong.Life product offering

Product offering

Core offering

Belong.Life develops and operates AI-powered patient engagement platforms combining generative-AI health mentors and disease-specific social/professional patient communities. Consumer-facing mobile apps (BelongAI Cancer Mentor Dave, BelongMS, BelongIBD, BelongPSO, Weight Mate Fred, Belong Cancer) provide 24/7 AI-driven guidance and peer support to patients with chronic conditions. Enterprise offerings include Smart Clinic AI, which automates clinical intake and administrative workflows for hospitals and clinics, and a white-label BelongAI platform licensed to pharmaceutical companies, payers, and clinical trial organizations for branded patient engagement deployments.

Product overview

Belong.Life is a global digital health company offering a multi-product platform combining AI-powered patient engagement tools with large-scale patient communities. The portfolio includes BelongAI Dave Cancer Mentor (a medically validated conversational AI companion), Smart Clinic AI (enterprise clinical workflow automation), Fred AI Weight Mate, consumer disease-specific communities (Belong Cancer, BelongMS, BelongIBD, BelongPSO), and enterprise solutions for Pharma, Payers, Hospitals/Clinics, Media Advertisers, and Clinical Trials. The company delivers these solutions on a private-label (white-label) basis. Products are available as mobile apps (iOS/Android) and web platforms, with all solutions sharing common AI infrastructure and compliance certifications (HIPAA, GDPR, ISO 27001).

Differentiator

Problem solved

Functional benefit

Brands

  • BelongAI Cancer Mentor (Dave): World's first proactive conversational AI Cancer Mentor, medically validated by world-leading physicians, providing proactive support and guidance powered by a community of peers.
  • BelongMS
  • BelongIBD
  • BelongPSO
  • Smart Clinic AI
  • Weight Mate (Fred)
  • iBelong

Products and services

  • BelongAI Dave — Cancer Mentor A proactive conversational AI cancer mentor mobile app that delivers 24/7 personalized support, guidance, and clinical-trial matching to cancer patients; medically validated by physicians and powered by a community of peers; available on iOS and Android as a freemium app with optional premium subscription.
  • Belong Cancer The world's largest social and professional network for cancer patients, caregivers, and healthcare professionals, providing community engagement, peer support, wellness resources, and education via a free, anonymous mobile app.
  • BelongMS The world's largest social and professional network for multiple sclerosis patients and caregivers, offering free, anonymous community support, resources, and tools for living with MS via a mobile app.
  • Smart Clinic AI Browser-based AI clinical workflow automation platform that automates patient intake, pre-visit interviews, document collection, and medical record summarization for hospitals and clinics; reduces administrative work by up to 60%, saves about 20 minutes per visit, and enables clinics to see up to 40% more patients per day at over 90% AI accuracy.
  • Fred — AI Weight Mate AI-powered mobile weight and health mentor that proactively supports users throughout weight loss, weight maintenance, and balanced living with personalized guidance.
  • BelongIBD Mobile patient community app providing support, education, and peer connection for patients with inflammatory bowel disease, Crohn's disease, and colitis.
  • BelongPSO Mobile patient community app delivering support, education, and peer connection for patients living with psoriasis.
  • iBelong Additional branded patient engagement app within the Belong.Life ecosystem offering patient community and engagement services.

Quantifiable outcome

  • Saves an average of 20 minutes per visit for clinics using Smart Clinic AI
  • +3 more outcomes

Companies that use Belong.Life

Customer profile

Named customers18 records

Segments6 records

Ideal customer profiles4 records

Belong.Life technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Belong.Life partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and strategic.

  • Sheba Medical CentercoreStrategic or Co-development PartnerMajor Israeli hospital partnering with Belong.Life for patient engagement solutions and research collaborations
  • Tel Aviv Sourasky Medical CentercoreStrategic or Co-development PartnerLeading Israeli medical center using Belong.Life patient engagement platforms
  • Rambam Health Care CampuscoreStrategic or Co-development PartnerMajor Israeli hospital partnering with Belong.Life for patient engagement
  • Janssen (Johnson & Johnson)coreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company using Belong.Life's white-label patient engagement platform
  • RochecoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company partnering with Belong.Life for patient engagement solutions
  • NovartiscoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company using Belong.Life's white-label patient engagement technology
  • SanoficoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company partnering with Belong.Life for patient engagement
  • AstraZenecacoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company using Belong.Life patient engagement platforms
  • BayercoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company partnering with Belong.Life for patient engagement
  • AbbViecoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company using Belong.Life's white-label patient engagement platform
  • MSDcoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company partnering with Belong.Life for patient engagement solutions
  • TakedacoreOEM/ Whitelabel/ Licensing PartnerPharmaceutical company using Belong.Life patient engagement platforms
  • TevacoreOEM/ Whitelabel/ Licensing PartnerIsraeli pharmaceutical company partnering with Belong.Life for patient engagement
  • ASCO (American Society of Clinical Oncology)coreStrategic or Co-development PartnerClinical validation research published at ASCO congresses on BelongAI Dave Cancer Mentor accuracy and clinical utility
  • ESMO (European Society for Medical Oncology)coreStrategic or Co-development PartnerClinical validation research published at ESMO congresses on BelongAI Cancer Mentor accuracy and recommendations
  • IQVIAstrategicTechnology or IntegrationHealthcare data and analytics company collaborating with Belong.Life for research and data capabilities
  • McGill UniversitystrategicStrategic or Co-development PartnerAcademic research partnership with Belong.Life for clinical research and validation studies
  • NCI (National Cancer Institute)coreStrategic or Co-development PartnerU.S. National Cancer Institute partnering with Belong.Life for cancer patient engagement research
  • GO2 Foundation for Lung CancerstrategicStrategic or Co-development PartnerNonprofit lung cancer organization partnering with Belong.Life for patient support and community engagement
  • Breast Health FoundationstrategicStrategic or Co-development PartnerBreast health nonprofit partnering with Belong.Life for patient community and support programs

Scale indicators7 records

Recent moves6 records

Expansion highlights3 records

Belong.Life competitors and assessment

Company assessment

Direct peers

  • GetWellNetwork: GetWellNetwork provides patient engagement, education, and workflow automation to hospitals and health systems — directly comparable to Belong's Smart Clinic AI and enterprise hospital channel.
  • PatientsLikeMe: PatientsLikeMe runs patient communities with structured health data and research partnerships, including pharma-sponsored modules — overlapping directly with Belong's community-plus-data monetization model.
  • CipherHealth: CipherHealth offers patient engagement, outreach, and care-navigation platforms to hospitals and health systems — overlapping with Belong's Smart Clinic AI patient intake and follow-up workflow automation.
  • HealthUnlocked: HealthUnlocked hosts condition-specific patient communities used by patient organizations and pharma — the closest pure community-platform analogue to Belong's flagship products.
  • MyHealthTeams: MyHealthTeams operates social networks for people living with chronic conditions (MS, breast cancer, autism, etc.) — directly comparable to Belong Cancer and BelongMS as condition-specific patient communities with pharma-sponsored programming.
  • Omada Health: Omada Health delivers digital chronic-disease management (diabetes, hypertension, weight) with payer and employer channels — comparable in chronic-condition focus, payer distribution, and quantified outcomes to Belong's payer enterprise solutions.
  • Sidekick Health: Sidekick Health delivers digital therapeutics and engagement platforms for chronic conditions with pharma and payer partnerships — directly comparable to Belong's condition-specific apps and enterprise white-label model.

Emerging players

  • Ada Health: Ada Health builds AI-driven symptom assessment and health navigation tools — overlapping with BelongAI's conversational guidance and clinical-trials matching use cases, though focused on triage rather than chronic-disease mentorship.
  • Tara AI (by Massive Bio): Massive Bio's Tara provides AI-powered oncology clinical-trial matching — directly comparable to BelongAI Tara (clinical trials matching) for pharma and CRO customers.

Broad incumbents

  • Verily Life Sciences: Verily (Alphabet) operates large-scale patient engagement, real-world data, and care management platforms across multiple conditions — a well-capitalized incumbent that competes with Belong's pharma, payer, and clinical-trial offerings at greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Belong.Life social profiles

Digital presence

Belong.Life compliance and trust

Trust signal

Compliance3 records

Belong.Life financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Belong.Life leadership team

Management profile

Number of profiles

Profiles5 records

Belong.Life funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Belong.Life M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Belong.Life

What does Belong.Life do?

Belong.Life develops and operates AI-powered patient engagement platforms combining generative-AI health mentors and disease-specific social/professional patient communities. Consumer-facing mobile apps (BelongAI Cancer Mentor Dave, BelongMS, BelongIBD, BelongPSO, Weight Mate Fred, Belong Cancer) provide 24/7 AI-driven guidance and peer support to patients with chronic conditions. Enterprise offerings include Smart Clinic AI, which automates clinical intake and administrative workflows for hospitals and clinics, and a white-label BelongAI platform licensed to pharmaceutical companies, payers, and clinical trial organizations for branded patient engagement deployments.

Is Belong.Life a public or private company?

Belong.Life is a private company. It is classified as venture growth investor backed and is currently operating.

When was Belong.Life founded?

Belong.Life was founded in 2015. It employs 51 to 100 people.

Where is Belong.Life based?

Belong.Life is headquartered in New York, United States, in the North America region.

How does Belong.Life make money?

Four revenue lines are on record. Freemium App Model is the primary driver. The others are enterprise White-Label Licensing, smart Clinic AI Enterprise Sales and premium Subscriptions (Paid Services).

Who are Belong.Life's main competitors?

Direct peers on record are GetWellNetwork, PatientsLikeMe, CipherHealth, HealthUnlocked, MyHealthTeams, Omada Health and Sidekick Health. Emerging players are Ada Health and Tara AI (by Massive Bio). Verily Life Sciences is listed as a broad incumbent.

Does Belong.Life have an API?

No public API is recorded for Belong.Life.

What industry is Belong.Life in?

Belong.Life's product category is Digital Health Patient Engagement Software. Its primary akta.pro industry code is HLACAEAK, Patient Community, Peer Support & Social Engagement, with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 624190 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Clinical Trials ArenaClinical Trials Arena Excellence Awards 2025: Belong.LifeBelong.Life received the Innovation Award in the Clinical Automation category at the 2025 Clinical Trials Arena Excellence Awards for its Smart Clinic AI platform, which automates patient intake, pre-visit interviews, document collection, and medical record summarization. The platform, used by hospitals and clinics in Israel, the U.S., and Europe, reportedly saves an average of 20 minutes per visit, reduces administrative work by up to 60%, and enables clinics to see up to 40% more patients per day, while maintaining over 90% accuracy overall. The solution is browser-based, HIPAA, GDPR, and ISO 27001 compliant, and is positioned as a scalable tool for reducing clinician administrative burden across solo practices to large hospital systems.PR NewswireEquiva and Belong.Life Partner to Equip Healthcare Providers with Validated Health AI Mentors for Better Patient OutcomesBelong.Life and Equiva announced a partnership to integrate Belong's AI health mentors into Equiva's digital platforms for in-hospital and home care. The collaboration is projected to generate around $10 million in revenue over the next three years. The AI mentors will be embedded directly within Equiva's platform for patient support.PR NewswireBelong.Life's Advanced AI Technology Selected to Power New Menopause Support SolutionBelong.Life announced that its AI Health Mentor SaaS solution will power 'Ask Elina,' a new app designed to help women navigate perimenopause and menopause. The platform, developed by co-founders Nathalie Belanger and Elizabeth Wasserman, leverages Belong's proprietary conversational AI to provide personalized, evidence-based symptom management and support. The application is scheduled to launch in May 2025.PR NewswireAbstract Published in ASCO 2024 Annual Meeting Book Showcases Validity of Belong.Life's Conversational AI Cancer Mentor 'Dave'Belong.Life announced that the American Society of Clinical Oncology (ASCO) published an abstract validating its AI cancer mentor, Dave, in the 2024 Annual Meeting Book. A multi-institutional study involving eight senior oncologists confirmed that 91.8% of Dave's responses were rated as relevant and helpful. The validation underscores the accuracy of the AI tool in supporting patients and caregivers with evidence-based medical information.NoCamelsSocial Media For Cancer Patients Offers Support And AdviceIsraeli startup Belong.Life has developed a social media platform and AI-driven tools to support cancer patients and their families with medical information, emotional guidance, and clinical trial matching. The company, which has raised over $30 million, reports significant adoption rates in Israel and the US while expanding its services to other chronic conditions like multiple sclerosis.PR NewswireBelong.Life Real-World Patient Research Analyzes the Impact of COVID-19 on Cancer Diagnosis in ASCO 2022 AbstractBelong.Life announced that the American Society of Clinical Oncology published its abstract in the 2022 Annual Meeting Abstract Book, presenting research on cancer diagnosis following COVID-19 infection based on anonymized data from the company's cancer patient app. The study of 124 participants found that 88% had a primary cancer diagnosis following COVID-19 infection, with the most prevalent cancers being breast, lung, and gastrointestinal, and 46% of cases occurring within six months of infection. The research highlights the need for further analysis into the intersection pathways of COVID-19 and cancer development or reactivation.PR NewswireBelong.Life Creates Dedicated Chronic Myeloid Leukemia Community Within World's Largest Cancer AppBelong.Life announced the launch of a dedicated chronic myeloid leukemia (CML) patient community within its Belong-Beating Cancer Together app, responding to numerous patient and caregiver requests for disease-specific support. The new community features educational content, support groups including CML General and CML Symptoms and Side Effects groups, and an innovative CML Tracker tool for patients to monitor symptoms over the course of their disease and treatment. The platform will be facilitated by Mel Mann, a 26-year CML survivor and patient advocate.PR NewswireBelong.Life Publishes Real-World Data on Effects of COVID-19 Vaccine on Cancer PatientsBelong.Life, a New York-based developer of patient social networks, published a real-world study showing unvaccinated cancer patients face a 21.5 times higher risk of COVID-19 infection compared to vaccinated patients. The study surveyed over 1,000 cancer patients, finding that only 0.41% of vaccinated patients contracted COVID-19 versus 8.9% of unvaccinated patients, with 97% of vaccinated participants experiencing no major side effects. The research findings were presented as a poster at the ESMO Virtual Congress 2021, providing encouraging evidence for the safety and necessity of COVID-19 vaccination in high-risk cancer populations.PR NewswireBelong.Life Launches i-Belong High-Engagement Platform, Allowing Providers, Health Plans, Advocacy Groups and Other Health Ecosystem Players to Easily Build Self-Managed Online Patient CommunitiesBelong.Life, a developer of global patient engagement platforms for cancer, multiple sclerosis, and other diseases, announced the launch of i-Belong, a self-managed platform enabling healthcare organizations, payers, providers, and patient advocacy groups to build customizable patient communities. The platform offers AI-powered engagement tools through a pay-as-you-grow subscription model and is HIPAA and GDPR compliant. The company is expanding its technology to the broader healthcare ecosystem, citing increased demand for digital patient communities highlighted during the COVID-19 pandemic.PR NewswireBelong.Life Launches All-in-One Networking and Navigation App to Support Multiple Sclerosis Patients and ProfessionalsBelong.Life announced the launch of BelongMS, a free AI-powered social networking and navigation platform for multiple sclerosis patients, caregivers, and healthcare professionals, building on the company's existing cancer management platform. The app provides hyper-personalized information, support groups, direct access to medical professionals, a medical binder manager for organizing records, and clinical trial matching using NLP algorithms that can match patients to trials within approximately two weeks. Originally launched in Israel where it has achieved significant traction with one in four local MS patients, the platform is now being expanded globally to serve the approximately 2.3 million people living with MS worldwide.